A detailed history of Obermeyer Wood Investment Counsel, Lllp transactions in Abb Vie Inc. stock. As of the latest transaction made, Obermeyer Wood Investment Counsel, Lllp holds 18,436 shares of ABBV stock, worth $3.64 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,436
Previous 18,073 2.01%
Holding current value
$3.64 Million
Previous $3.29 Million 3.92%
% of portfolio
0.18%
Previous 0.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $56,188 - $65,615
363 Added 2.01%
18,436 $3.16 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $1.22 Million - $1.39 Million
7,613 Added 72.78%
18,073 $3.29 Million
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $16,512 - $18,596
120 Added 1.16%
10,460 $1.62 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $55,974 - $64,798
419 Added 4.22%
10,340 $1.54 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $41,873 - $52,108
-316 Reduced 3.09%
9,921 $1.34 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $148,514 - $171,036
-1,027 Reduced 9.12%
10,237 $1.63 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $37,343 - $44,784
-270 Reduced 2.34%
11,264 $1.82 Million
Q3 2022

Dec 09, 2022

SELL
$134.21 - $153.93 $51,670 - $59,263
-385 Reduced 3.23%
11,534 $1.55 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $93,168 - $118,447
677 Added 6.02%
11,919 $1.83 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $1,187 - $1,473
-9 Reduced 0.08%
11,242 $1.82 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $1,718 - $2,174
-16 Reduced 0.14%
11,251 $1.52 Million
Q3 2021

Oct 19, 2021

SELL
$106.4 - $120.78 $23,620 - $26,813
-222 Reduced 1.93%
11,267 $1.22 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $71,963 - $80,171
684 Added 6.33%
11,489 $1.29 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $418,816 - $461,066
4,094 Added 61.0%
10,805 $1.17 Million
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $13,280 - $17,930
165 Added 2.52%
6,711 $719,000
Q3 2020

Oct 22, 2020

SELL
$85.91 - $100.83 $20,532 - $24,098
-239 Reduced 3.52%
6,546 $573,000
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $9,317 - $12,468
127 Added 1.91%
6,785 $666,000
Q1 2020

Apr 30, 2020

SELL
$64.5 - $97.79 $24,058 - $36,475
-373 Reduced 5.31%
6,658 $507,000
Q4 2019

Feb 03, 2020

SELL
$72.13 - $90.25 $20,412 - $25,540
-283 Reduced 3.87%
7,031 $623,000
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $50,384 - $60,576
-800 Reduced 9.86%
7,314 $554,000
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $500,042 - $639,171
-7,611 Closed
0 $0
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $26,999 - $31,776
-350 Reduced 4.4%
7,611 $613,000
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $56,102 - $62,368
631 Added 8.61%
7,961 $753,000
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $30,884 - $36,543
-344 Reduced 4.48%
7,330 $679,000
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $80,508 - $107,808
-875 Reduced 10.24%
7,674 $726,000
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $140,071 - $153,600
1,564 Added 22.39%
8,549 $827,000
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $487,902 - $623,201
6,985
6,985 $621,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Obermeyer Wood Investment Counsel, Lllp Portfolio

Follow Obermeyer Wood Investment Counsel, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Obermeyer Wood Investment Counsel, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Obermeyer Wood Investment Counsel, Lllp with notifications on news.